ITOVEBI

Formula & Concentration

ITOVEBI – inavolisib 3 mg and 9 mg tablet

Manufacturer

Genentech Inc

Indications

HR(+), HER2(-), PIK3CA mutated advanced breast cancer

Product Options

Package Size

NDC #

Presentation

3 MG

50242-0084-08

TABLET

9 MG

50242-0079-08

TABLET

Shelf Life and Storage

Controlled Room Temp (20-25°C)